Skip to main content

Closed

VNDA: Vanda Pharmaceuticals Inc. Financial Statements & Revenue | finqOS

Healthcare · Biotechnology

52W Range

17thpctl

Volume

0.55×avg

Market Cap

306.69MUSD

P/E Ratio

-1.3TTM

Div Yield

-ann

Vanda Pharmaceuticals Inc.

VNDANASDAQ Global Market·USD·Closed

Vanda Pharmaceuticals Inc.

VNDANASDAQ·USD·Closed

$5.10

−1.54%

$5.10

−$0.08 (1.54%)

52W Range

17thpctl

Volume

0.55×avg

Mkt Cap

306.69MUSD

P/E

-1.3TTM

Div Yield

–ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings